These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 22994156)

  • 41. Tinea capitis: a treatment update.
    Roberts BJ; Friedlander SF
    Pediatr Ann; 2005 Mar; 34(3):191-200. PubMed ID: 15792111
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A network meta-analysis on the efficacy and safety of monotherapies for tinea capitis, and an assessment of evidence quality.
    Gupta AK; Bamimore MA; Renaud HJ; Shear NH; Piguet V
    Pediatr Dermatol; 2020 Nov; 37(6):1014-1022. PubMed ID: 32897584
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lack of efficacy of 6-week treatment with oral terbinafine for tinea capitis due to Microsporum canis in children.
    Dragos V; Lunder M
    Pediatr Dermatol; 1997; 14(1):46-8. PubMed ID: 9050765
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparative double-blind study of terbinafine (Lamisil) and griseofulvin in tinea corporis and tinea cruris.
    del Palacio Hernandez A; López Gómez S; González Lastra F; Moreno Palancar P; Iglesias Díez L
    Clin Exp Dermatol; 1990 May; 15(3):210-6. PubMed ID: 2194715
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic efficacy of terbinafine in the treatment of three children with tinea tonsurans.
    Desgarennes MD; Godoy MR; Palencia AB
    J Am Acad Dermatol; 1996 Jul; 35(1):114-6. PubMed ID: 8682948
    [No Abstract]   [Full Text] [Related]  

  • 46. Tinea Capitis: An Updated Review.
    Leung AKC; Hon KL; Leong KF; Barankin B; Lam JM
    Recent Pat Inflamm Allergy Drug Discov; 2020; 14(1):58-68. PubMed ID: 31906842
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral treatment of tinea corporis and tinea cruris with terbinafine and griseofulvin: a randomized double blind comparative study.
    Voravutinon V
    J Med Assoc Thai; 1993 Jul; 76(7):388-93. PubMed ID: 8089640
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of tinea capitis - griseofulvin versus fluconazole - a comparative study.
    Shemer A; Plotnik IB; Davidovici B; Grunwald MH; Magun R; Amichai B
    J Dtsch Dermatol Ges; 2013 Aug; 11(8):737-41, 737-42. PubMed ID: 23575220
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Tinea capitis: clinical features and therapeutic alternatives].
    Messina F; Walker L; Romero MLM; Arechavala AI; Negroni R; Depardo R; Marin E; Santiso GM
    Rev Argent Microbiol; 2021; 53(4):309-313. PubMed ID: 33618899
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparable efficacy and safety of various topical formulations of terbinafine in tinea pedis irrespective of the treatment regimen: results of a meta-analysis.
    Korting HC; Kiencke P; Nelles S; Rychlik R
    Am J Clin Dermatol; 2007; 8(6):357-64. PubMed ID: 18039018
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An experience from an outbreak of tinea capitis gladiatorum due to Trichophyton tonsurans.
    Ergin S; Ergin C; Erdoğan BS; Kaleli I; Evliyaoğlu D
    Clin Exp Dermatol; 2006 Mar; 31(2):212-4. PubMed ID: 16487093
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The assessment and management of tinea capitis in children.
    Ali S; Graham TA; Forgie SE
    Pediatr Emerg Care; 2007 Sep; 23(9):662-5; quiz 666-8. PubMed ID: 17876261
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and tolerability of 8 weeks' treatment with terbinafine in children with tinea capitis caused by Microsporum canis: a comparison of three doses.
    Devliotou-Panagiotidou D; Koussidou-Eremondi TH
    J Eur Acad Dermatol Venereol; 2004 Mar; 18(2):155-9. PubMed ID: 15009293
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tinea capitis versus acne keloidalis nuchae with Trichophyton violaceum superinfection.
    Veraldi S; La Vela V; Tavecchio S
    G Ital Dermatol Venereol; 2011 Jun; 146(3):247-8. PubMed ID: 21566556
    [No Abstract]   [Full Text] [Related]  

  • 55. An open study of tinea capitis in 50 children treated with a 2-week course of oral terbinafine.
    Krafchik B; Pelletier J
    J Am Acad Dermatol; 1999 Jul; 41(1):60-3. PubMed ID: 10411412
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systemic antifungal treatment of children with terbinafine.
    Bruckbauer HR; Hofmann H
    Dermatology; 1997; 195(2):134-6. PubMed ID: 9310719
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Doubled dose of oral terbinafine is required for Microsporum canis tinea capitis.
    Koumantaki E; Kakourou T; Rallis E; Riga P; Georgalla S
    Pediatr Dermatol; 2001; 18(4):339-42. PubMed ID: 11576412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tinea in Tots: Cases and Literature Review of Oral Antifungal Treatment of Tinea Capitis in Children under 2 Years of Age.
    Zampella JG; Kwatra SG; Blanck J; Cohen B
    J Pediatr; 2017 Apr; 183():12-18.e3. PubMed ID: 28088394
    [No Abstract]   [Full Text] [Related]  

  • 59. Tinea capitis: no incision nor excision.
    von Laer Tschudin L; Laffitte E; Baudraz-Rosselet F; Dushi G; Hohlfeld J; de Buys Roessingh AS
    J Pediatr Surg; 2007 Aug; 42(8):E33-6. PubMed ID: 17706485
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tinea capitis: an overview with emphasis on management.
    Gupta AK; Hofstader SL; Adam P; Summerbell RC
    Pediatr Dermatol; 1999; 16(3):171-89. PubMed ID: 10383772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.